MedPath

Development of a Culturally Tailored Resilience-building Intervention for Chinese American's Advance Care Planning Discussions

Not Applicable
Recruiting
Conditions
Advance Care Planning
Heart Diseases
Neoplasms
Interventions
Behavioral: Culturally tailored resilience-building intervention
Registration Number
NCT06247215
Lead Sponsor
University of Illinois at Chicago
Brief Summary

Less than 15% of Chinese Americans complete advance directives. That is less than half of the 37% completion rate in the US general population. This disparity in the use of advance care planning between White Americans and Chinese Americans may extend to disparities in end-of-life care. To address such disparities in end-of-life care, we will develop and assess the acceptability of a culturally tailored resilience-building intervention to help Chinese Americans with cancer or heart disease and their family caregivers engage in advance care planning discussions.

Detailed Description

The overall objective of this cross-sectional pilot study is to develop a culturally tailored resilience-building intervention for Chinese Americans with cancer or heart disease in Chicago. A qualitative analysis of semi-structured interviews will be conducted to identify how religious leaders addressed death-related topics with Chinese Americans with cancer or heart disease in Chicago. In addition, a usability test of a resilience-building intervention prototype will be conducted to to understand the feasibility and acceptability among 18 pairs of Chinese Americans and their family caregivers (9 pairs with cancer and 9 pairs with heart disease).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
36
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ExperimentalCulturally tailored resilience-building interventionParticipants will evaluate the culturally-tailored resilience-building intervention prototype
Primary Outcome Measures
NameTimeMethod
AcceptabilityImmediately at the end of the usability testing

The Theoretical Framework of Acceptability, which ranges from 1 to 5, will be used to assess acceptability. A higher score indicates higher acceptability.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Illinois Chicago

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath